We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The JAMA Forum |

Community Approaches to the Opioid Crisis FREE

Howard Koh, MD, MPH1
[+] Author Affiliations
1Howard Koh, MD, MPH, is the Harvey V. Fineberg Professor of the Practice of Public Health Leadership at the Harvard T. H. Chan School of Public Health and the Harvard Kennedy School. He is also the former Massachusetts commissioner of public health and the 14th assistant secretary for health for the US Department of Health and Human Services. A quadruple-boarded physician, Dr Koh has published more than 250 articles in medical and public health literature, earned more than 70 awards for interdisciplinary achievements in public health, and has received 5 honorary doctorate degrees.
JAMA. 2015;314(14):1437-1438. doi:10.1001/jama.2015.12346.
Text Size: A A A
Published online

The abuse of opioids continues to have a devastating effect throughout the United States, as 2 recent studies highlight.

Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Howard Koh, MD, MPH

Harvard T.H. Chan School of Public Health

The first study, a national poll by the Harvard T. H. Chan School of Public Health and the Boston Globe, found that about 40% of respondents personally knew someone who had abused or misused prescription pain medicines such as hydrocodone in the past 45 years (http://bit.ly/1JHYqtd). Only about 45% believed that long-lasting treatment was effective for opioid dependency.

The second study, from the Centers for Disease Control and Prevention and the Food and Drug Administration (FDA), found that heroin abuse, traditionally more common among men and the poor, is now rising rapidly in groups such as women, the privately insured, and those of higher income (http://1.usa.gov/1Fo8QtT).

These findings represent just the tip of the iceberg. From 2001-2013, the annual number of overdose deaths rose 3-fold for prescription opioid analgesics (to more than 16 200) and 5-fold for heroin (to more than 8200 deaths) (http://1.usa.gov/1znaUDW). Such trends parallel the steady increase in opioid analgesics to 259 million prescriptions a year, enough for each American adult (http://1.usa.gov/1JFmWJg).

People can readily access and misuse legal drugs in the medicine cabinet prescribed for others. Three-quarters of new users of heroin, a cheaper and more readily available opioid, initially began using prescription painkillers for nonmedical reasons. Researchers cite additional factors, such as aggressive pain treatment as a desired feature of quality care, availability of new formulations, pharmaceutical marketing, and previous underappreciation of addiction risk by professionals and public alike, as contributing to these trends.

Currently, nearly 2 million people abuse or are dependent on prescription opioids and more than half a million abuse or are dependent on heroin (http://1.usa.gov/1rpXmxJ). Multiple drug use, involving alcohol and sedatives for example, can increase overdose risk. Further complicating the picture are HIV and hepatitis C associated with intravenous use.

The crisis has triggered a dramatic response nationwide. Federal agencies, such as the White House Office of National Drug Control Policy (ONDCP) and the US Department of Health and Human Services, have offered comprehensive strategies to prevent opioid abuse and overdose. State and local leaders, including elected officials, have led a surge of community activity on the following fronts:


Clinicians are striving for a finer balance that meets the patient’s need for pain relief while minimizing chances for abuse. Updated professional education efforts promote state-based and specialty society-based prescribing guidelines that encourage separate treatment approaches for acute and chronic pain; careful consideration of abuse risk before prescribing; “contracts” that clarify expectations, goals, and responsibilities for patients and prescribers; and use of the lowest effective dose for the shortest possible duration.

In addition, community public education efforts have encouraged safer disposal of unused medicines from the home. Research to reduce the supply of unsafe analgesics has prioritized creating deterrent forms of pills that cannot be crushed and abused, as well as novel painkillers with little or no abuse potential.


Prescription drug monitoring programs (PDMPs), which electronically track prescriptions of all controlled drugs, now operate in 49 states (except Missouri) and Washington, DC (http://nyti.ms/1u8aKxQ). PDMPs can identify possible nonmedical use and diversion. Physicians can connect to them as part of prescribing while pharmacists can check them before dispensing.

A preliminary analysis of mandated PDMP use in Kentucky, Tennessee, and New York showed fewer episodes of patients seeking prescription opioids from multiple providers (http://bit.ly/1IP9kJP). Nonetheless, many PDMPs still need substantial improvements to reach the ideal in which they are easy to use, offer standardized content, update information in real time, and demonstrate interstate accessibility. Also, a new national initiative pairs law enforcement with public health officials to better trace and monitor trafficking of heroin, which in some states is now often laced with fentanyl, a powerful synthetic opioid.


Naloxone (Narcan), which temporarily reverses the respiratory depression associated with opiate overdose, can prevent opioid-related death. Although it is traditionally administered intravenously in the medical setting, the availability of an intranasal formulation now allows ready use in the field by laypersons and first responders—fire and police department personnel.

A recent survey notes that expanded naloxone use by laypersons, viewed as safe and cost-effective, has now reached 30 states and Washington, DC (http://1.usa.gov/1NgErFz). In 2014, the FDA approved a naloxone autoinjector that could further expand usage.


Tocounter public misperceptions about treatment futility, ONDCP Director Michael Botticelli, MEd, emphasizes showing “hope on the other side” of addiction (http://bit.ly/1OiADRA). Citing his personal perspective as a person in recovery, Botticelli promotes the proven value of linking people to care through a continuum of services, including medication-assisted treatment (including buprenorphine, methadone, and naltrexone), counseling, and behavioral therapy. Promising approaches also include using the emergency department setting to initiate buprenorphine for opioid-dependent patients (as opposed to brief intervention and referral), as well as to connect with recovery coaches (http://bit.ly/1bSDRxm).

Long-term success requires substantially improving treatment capacity that has been chronically underresourced with respect to facilities and trained clinicians. The Affordable Care Act (2010) and the Mental Health Parity and Addiction Equity Act (2008) offer major opportunities to improve insurance coverage and treatment, but barriers for smooth implementation remain. Meanwhile, community-based coalitions, involving local schools, youth groups, law enforcement and faith-based organizations, among others, have heightened public education about the power of prevention.


Media stories about how the opioid crisis cuts short promising lives are renewing public attention, commitment, and concern. Viewing substance use disorders as a chronic disease that waxes and wanes, not as a moral failing, may help overcome stigma that prevents affected people from seeking treatment. Encouraging public dialogue that refers to a “person with a substance use disorder” (instead of “addict”) and “person in recovery” (instead of “former addict”) can medicalize what many still view as primarily a criminal problem.

The heightened national response to the current opioid crisis, although noteworthy, must be deepened and sustained. Although prescription opioid-related deaths have leveled in the last several years, the country has not yet documented the progress seen with other substance abuse areas, such as tobacco dependence and underage drinking. Overcoming the opioid crisis will require the highest level of commitment of communities, clinicians, public health, and public safety for many years to come.


Corresponding Author: Howard Koh, MD, MPH (hkoh@hsph.harvard.edu)

Published online: September 2, 2015, at http//:newsatjama.jama.com/category/the-jama-forum/.

Disclaimer: Each entry in The JAMA Forum expresses the opinions of the author but does not necessarily reflect the views or opinions of JAMA, the editorial staff, or the American Medical Association.

Additional Information: Information about The JAMA Forum is available at http://newsatjama.jama.com/about/. Information about disclosures of potential conflicts of interest may be found at http://newsatjama.jama.com/jama-forum-disclosures/.


Place holder to copy figure label and caption

Graphic Jump LocationImage not available.

Howard Koh, MD, MPH

Harvard T.H. Chan School of Public Health



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Care at the Close of Life: Evidence and Experience
Use of Opioid Analgesics for a Pain Crisis in an Inpatient Setting

Care at the Close of Life: Evidence and Experience
Pain Management and Symptomatic Measures